AI summary by TwinMind

The Science of Psychedelics for Mental Health | Dr. Robin Carhart-Harris

Andrew Huberman

2h 37m 9s

Introduction and Etymology of Psychedelics

  • Dr. Robin Carhart-Harris: distinguished professor neurology/psychiatry UCSF, leading psychedelics researcher
  • Psychedelic etymology: coined 1956 by Humphry Osmond for National Academy Sciences meeting
    • Replaced "psychotomimetics" (drugs mimicking psychosis)
    • Ancient Greek: "psyche" (mind/soul) + "delos" (to reveal/make manifest)
    • Osmond's ditty: "to fathom hell or soar angelic, just take a pinch of psychedelic"
  • Definition debate: pharmacological (serotonin 2A receptor agonists) vs phenomenological (subjective experience)
  • Classic psychedelics: LSD, psilocybin, DMT - all work via serotonin 2A receptor

Psychedelics and the Unconscious

  • Psychedelics reveal aspects of psyche ordinarily not visible
  • Different from blindsight (non-conscious processing below awareness threshold)
  • Access personal unconscious: repressed memories, difficult relationships, trauma
  • Access collective unconscious (Jung): transpersonal aspects of human psyche
  • Historical use in psychotherapy: material emerges with strong emotional release, cathartic experiences, insights
  • This "psyche-revealing" action is what makes classic psychedelics unique vs other compounds

Clinical Trial Methodology and Dosing

  • Psilocybin dosing: 25mg therapeutic dose, 10mg comparison, 1mg placebo/microdose
  • Magic mushroom conversion: ~1% psilocybin content by weight (1g mushroom ≈ 10mg psilocybin)
  • Microdosing definition: sub-perceptible doses taken semi-regularly
    • LSD: ~10-12 micrograms threshold
    • Evidence for microdosing benefits currently thin/lacking compelling data
  • Imperial College study: citizen science microdosing showed mostly placebo effects
    • Those thinking they got microdose (but got placebo) performed as well as actual microdosers

Therapeutic Session Structure

  • Standard protocol across sites: settled conditions, music throughout, eye masks
  • Two therapists present (ideally mental health professionals)
  • Music progression: spacious beginning → atmospheric build → emotional strings
  • Music appears critical but hasn't been formally tested as variable
  • "Psychedelic-therapy" (hyphenated): combination treatment with positive interaction

Journey Phases and "Letting Go"

  • Initial phase: anxiety, struggle against drug effects, fear of losing mind/dying
  • Core mantra: "Trust, let go, be open" (attributed to Bill Richards)
    • Trust: therapeutic rapport (measured, predicts outcomes)
    • Let go: readiness to surrender, not resist
    • Be open: willingness to confront difficult material
  • Student Harry Brouwer's research: early phase dominated by negative emotions, latter half different
  • Initial struggle typically against general drug effects rather than specific content

Brain Changes and Connectivity

  • Acute effects: increased global functional connectivity between brain modules
  • Normally modular communication (visual system talks within visual system)
  • Psilocybin: communication transcends modules, becomes inter-modular
  • Effect correlates with subjective experience magnitude
  • Replicated with LSD, upcoming DMT paper shows similar effects
  • Computational modeling confirms serotonin 2A receptor activation causes this effect

Long-term Brain Changes

  • Increased connectivity persists: seen day after and 3 weeks post-session
  • Magnitude correlates with therapeutic improvement in depression
  • Decreased modularity may represent more flexible brain functioning
  • Depression analogy: stuck in rut, cut off from other modalities/world
  • Healthy volunteers study: anatomical brain changes in white matter tracts
    • Decreased axial diffusivity in prefrontal-thalamic/striatal tracts
    • Similar to healthy brain development (opposite of aging/pathology)
    • Improved cognitive flexibility, psychological well-being

Clinical Trial Results

Depression Trials

  • Psilocybin vs escitalopram (Lexapro) trial: New England Journal Medicine 2022
  • Two sessions typically, 1-3 weeks apart
  • Expectancy analysis: pre-trial expectations predicted SSRI response but NOT psilocybin response
    • Challenges idea that psychedelic therapy is "super placebo"
  • Treatment-resistant depression: majority show initial improvement but many relapse by 3+ months
  • Some patients from first trial still well, back at work, but majority relapsed
  • Participants denied continued treatment post-trial due to legal restrictions

Other Conditions

  • Anorexia trial: 3 sessions, 2 weeks apart, 19 patients completed
    • Improved weight at long-term follow-up
    • Very exciting preliminary results
  • Fibromyalgia study: chronic generalized pain condition
    • 8 patients treated, going very well
    • Single dose with EEG monitoring
    • Profound experiences reported, no specific pain focus during sessions

Integration and Long-term Practice

  • Integration potentially lasts lifetime - "after the ecstasy, the laundry" (Jack Kornfield)
  • Therapeutic teams can't provide lifetime support
  • May become personal practice like meditation
  • Some consider "psychedelic practice" similar to meditation practice
  • Meditation/mindfulness as important complement: ability to "sit with rather than sit on"
  • Repeated dosing may be needed for some conditions

DMT and Ego Dissolution

  • DMT: "rocket ship" compared to psilocybin's "ship leaving port"
  • Serotonin 2A agonist, less potent than psilocybin but effects when smoked/vaped are intense
  • 5-methoxy-DMT: more reliable ego dissolution, less visual, more immersive
  • Ego dissolution: breakdown of self/other boundaries
    • Positive aspect: feeling interconnected with others/world
    • Recognition that ego is mental construction
    • Serotonin 2A receptors heavily expressed in "recent brain" (evolutionarily recent cortex)
    • Classic psychedelics cause this, MDMA less so
  • Cocaine opposite effect: ego inflation via dopamine system

MDMA Comparison and Combinations

  • MDMA: empathogen, easier access to difficult material, more directionally positive
  • Classic psychedelics: can be "aggressively" deep, sometimes overwhelming for trauma
  • Underground therapists use psilocybin/MDMA combinations ("hippy flip")
  • MDMA allows safer return to trauma without dissociation/flashbacks
  • Limitation: may not go as deep as classic psychedelics
  • Classic psychedelics offer "honesty" - hell as well as heaven

Current Legal Landscape and Future

MDMA Timeline

  • MAPS completed two Phase III trials for PTSD
  • ~67% remission rates, long-term benefits (years)
  • FDA filing happening now, potential approval 2023-2024
  • MAPS may become provider, therapist training requirements being determined
  • Referral process unclear (psychiatrist vs GP)

Psilocybin Timeline

  • Compass running Phase III trials for treatment-resistant depression
  • Estimated completion ~2026
  • Multiple research centers globally studying various conditions
  • Groundswell of positive results across psychiatric disorders

Decriminalization vs Legalization

  • Oakland: decriminalized, some head shops selling openly
  • Churches claiming religious exemption
  • Federal FDA approval needed for nationwide medical access
  • Current participants can't access treatment post-trial legally

Risks and Safeguards

  • Boundary crossing scandals in psychedelic therapy community
  • Importance of proper training, standards, safeguards
  • Fentanyl contamination in street psychedelics - serious safety concern
  • Need to avoid repeating 1970s backlash that shut down research
  • Balance needed as field develops rapidly

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome